Home/Filings/4/0001225208-26-000696
4//SEC Filing

Corkrean John J 4

Accession 0001225208-26-000696

CIK 0000039368other

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 12:42 PM ET

Size

24.0 KB

Accession

0001225208-26-000696

Research Summary

AI-generated summary of this filing

Updated

H.B. Fuller CFO John Corkrean Receives 2,943-Share Award

What Happened
John J. Corkrean, Executive Vice President and Chief Financial Officer of H.B. Fuller (FUL), was granted 2,943 performance stock units on Jan. 20, 2026. The award is recorded as a derivative grant with an acquisition price of $0 (no cash paid). These performance stock units convert into common shares on a 1-for-1 basis upon vesting and are contingent on performance metrics.

Key Details

  • Transaction date: 2026-01-20; Form 4 filed: 2026-01-22.
  • Grant type: Performance stock units (derivative award), 2,943 units, acquisition price $0.
  • Vesting/settlement: Footnote F2 — each unit represents a contingent right to one share on vesting date of Jan. 24, 2026; the reported amount reflects an 80% payout level for the return-on-invested-capital (ROIC) performance metric. Footnote F1 notes these PSUs convert 1-for-1 into common shares.
  • Shares owned after transaction: not specified in the provided filing.
  • Filing timeliness: No indication of a late filing in the supplied data (filed two days after the transaction).

Context
This was a compensation award (not an open-market purchase or sale). Performance stock unit grants are common executive compensation tied to future performance and do not represent immediate cash proceeds or a sale of shares. These awards can become share ownership if performance and vesting conditions are met.

Insider Transaction Report

Form 4
Period: 2026-01-20
Corkrean John J
Executive VP and CFO
Transactions
  • Award

    Performance Stock Units

    [F1][F2]
    2026-01-20+2,9432,943 total
    Exercise: $0.00From: 2026-01-24Exp: 2026-01-24Common Stock (2,943 underlying)
Holdings
  • Common Stock

    54,646
  • Employee Stock Option (Right-to-Buy)

    [F3]
    Exercise: $45.05From: 2020-01-24Exp: 2029-01-24Common Stock (41,208 underlying)
    41,208
  • Employee Stock Option (Right-to-Buy)

    [F3]
    Exercise: $48.35From: 2021-01-24Exp: 2030-01-24Common Stock (48,309 underlying)
    48,309
  • Employee Stock Option (Right-to-Buy)

    [F3]
    Exercise: $50.10From: 2018-01-26Exp: 2027-01-26Common Stock (23,696 underlying)
    23,696
  • Employee Stock Option (Right-to-Buy)

    [F3]
    Exercise: $51.89From: 2022-01-27Exp: 2031-01-27Common Stock (38,376 underlying)
    38,376
  • Employee Stock Option (Right-to-Buy)

    [F3]
    Exercise: $53.57From: 2019-01-25Exp: 2028-01-25Common Stock (21,834 underlying)
    21,834
  • Employee Stock Option (Right-to-Buy)

    [F4]
    Exercise: $64.28From: 2026-01-27Exp: 2035-01-27Common Stock (24,570 underlying)
    24,570
  • Employee Stock Option (Right-to-Buy)

    [F4]
    Exercise: $68.17From: 2024-01-24Exp: 2033-01-24Common Stock (22,312 underlying)
    22,312
  • Employee Stock Option (Right-to-Buy)

    [F3]
    Exercise: $72.94From: 2023-01-24Exp: 2032-01-24Common Stock (21,997 underlying)
    21,997
  • Employee Stock Option (Right-to-Buy)

    [F4]
    Exercise: $77.72From: 2025-01-26Exp: 2034-01-26Common Stock (24,774 underlying)
    24,774
  • Phantom Units

    [F5][F6][F7]
    Exercise: $0.00Common Stock (28,248.05 underlying)
    28,248.05
  • Restricted Stock Units

    [F8][F9][F10]
    Exercise: $0.00From: 2024-01-24Exp: 2026-01-24Common Stock (1,302.35 underlying)
    1,302.35
  • Restricted Stock Units

    [F8][F9][F10]
    Exercise: $0.00From: 2025-01-26Exp: 2027-01-26Common Stock (2,852.64 underlying)
    2,852.64
  • Restricted Stock Units

    [F8][F9][F10]
    Exercise: $0.00From: 2026-01-27Exp: 2028-01-27Common Stock (4,370.58 underlying)
    4,370.58
Footnotes (10)
  • [F1]These performance stock units convert into shares of common stock on a 1-for-1 basis.
  • [F10]Amount includes restricted stock units acquired pursuant to a dividend equivalent reinvestment feature.
  • [F2]Each performance stock unit represents a contingent right to receive one share of H.B. Fuller common stock on the vesting date of January 24, 2026. This amount represents H.B. Fuller achieving return on invested capital payout at 80% of the target level.
  • [F3]This option is 100% vested.
  • [F4]This option vests in three annual installments (33%, 33%, and 34%) beginning on the date shown.
  • [F5]These units (acquired after 12-31-04) convert into shares of common stock on a 1-for-1 basis.
  • [F6]These units (acquired after 12-31-04) convert into shares of common stock upon the earlier of certain termination events as specified in the Key Employee Deferred Compensation Plan or such earlier date as selected by the participant, subject to holding periods required by law.
  • [F7]Amount includes stock units acquired pursuant to a dividend equivalent feature.
  • [F8]These restricted stock units convert into shares of common stock on a 1-for-1 basis.
  • [F9]These restricted stock units vest in three annual installments (33%, 33%, and 34%) beginning on the date shown.
Signature
/s/ Patrick J. Seul, Attorney-in-Fact|2026-01-22

Documents

1 file

Issuer

FULLER H B CO

CIK 0000039368

Entity typeother

Related Parties

1
  • filerCIK 0001431849

Filing Metadata

Form type
4
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 12:42 PM ET
Size
24.0 KB